144
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Miller Fisher Variant of Guillain-Barré Syndrome Triggered by Ventilator-Associated Pneumonia

, , , , , ORCID Icon, & show all
Pages 339-342 | Published online: 20 May 2021

References

  • Doets AY, Verboon C, van den Berg B, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–2877. doi:10.1093/brain/awy232
  • Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56(8):1104–1106. doi:10.1212/WNL.56.8.1104
  • Ito M, Kuwabara S, Odaka M, et al. Bickerstaff ’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol. 2008;255:674–682. doi:10.1007/s00415-008-0775-0
  • Lee SY, Lee YH, Chun BY, et al. An adult case of fisher syndrome subsequent to mycoplasma pneumoniae infection. J Korean Med Sci. 2013;28(1):152–155. doi:10.3346/jkms.2013.28.1.152
  • Bernal Sánchez-Arjona M, Franco Macías E, Villalobos-Chaves F. [Miller Fisher syndrome in the course of an acute pneumonia by Mycoplasma pneumoniae. Rev Neurol. 2003;36(3):235–237. doi:10.33588/rn.3603.2002236
  • Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016;12(11):1175–1189. doi:10.1080/1744666X.2016.1193006
  • Nobile-Orazio E. The complement story in Guillain-Barré syndrome: from pathogenesis to therapy. Lancet Neurol. 2018;17(6):483–485. doi:10.1016/S1474-4422(18)30144-3
  • Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid. Neuroimmunol. 2004;148(1–2):200–205. doi:10.1016/j.jneuroim.2003.11.017
  • Koga M, Gilbert M, Takahashi M, et al. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol. 2012;259(7):1366–1374. doi:10.1007/s00415-011-6360-y
  • Leonhard SE, Mandarakas MR, Gondim FA, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671–683. doi:10.1038/s41582-019-0250-9
  • Van Den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469. doi:10.1038/nrneurol.2014.121
  • Khadilkar SV, Yadav RS, Patel BA. Miller Fisher Syndrome. In: Neuromuscular Disorders. Singapore: Springer; 2018:531–534).
  • Lyu RK, Tang LM, Hsu WC, Chen ST. Quantitative cardiovascular autonomic function study in Fisher syndrome. J Neurol Neurosurg Psychiatry. 2002;73(3):333–335. doi:10.1136/jnnp.73.3.333
  • Yuan CL, Wang YJ, Tsai CP. Miller fisher syndrome: a hospital-based retrospective study. Eur Neurol. 2000;44(2):79–85. doi:10.1159/000008201
  • Kordouni M, Jibrini M, Siddiqui MA. Long-term transvenous temporary pacing with active fixation bipolar lead in the management of severe autonomic dysfunction in Miller-Fisher syndrome: a case report. Int J Cardiol. 2007;117(1):e10–e12. doi:10.1016/j.ijcard.2006.07.086
  • Kaushik P, Cohen AJ, Zuckerman SJ, et al. Miller fisher variant of guillain-barre syndrome requiring a cardiac pacemaker in a patient on tacrolimus after liver transplantation. Ann Pharmacother. 2005;39(6):1124–1127. doi:10.1345/aph.1E676
  • Ding L, Chen Z, Sun Y, et al. Guillain-Barré syndrome following bacterial meningitis: a case report and literature review. BMC Neurol. 2018;18. doi:10.1186/s12883-018-1211-4